Chesley Taft & Associates LLC Reduces Stock Holdings in Corteva, Inc. $CTVA

Chesley Taft & Associates LLC reduced its position in shares of Corteva, Inc. (NYSE:CTVA) by 52.5% in the 4th quarter, Holdings Channel.com reports. The firm owned 17,289 shares of the company’s stock after selling 19,076 shares during the quarter. Chesley Taft & Associates LLC’s holdings in Corteva were worth $1,159,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Activest Wealth Management grew its stake in shares of Corteva by 118.3% in the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after buying an additional 200 shares during the period. JPL Wealth Management LLC acquired a new stake in shares of Corteva during the 3rd quarter worth approximately $25,000. True Wealth Design LLC raised its position in shares of Corteva by 209.5% during the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after buying an additional 264 shares during the period. Total Investment Management Inc. acquired a new position in Corteva in the second quarter valued at approximately $27,000. Finally, Twin Peaks Wealth Advisors LLC acquired a new position in Corteva in the second quarter valued at approximately $29,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Stock Up 0.0%

Shares of NYSE CTVA opened at $82.00 on Monday. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The business’s 50 day moving average is $76.25 and its two-hundred day moving average is $69.65. Corteva, Inc. has a 52-week low of $53.40 and a 52-week high of $82.89. The firm has a market cap of $55.05 billion, a price-to-earnings ratio of 51.90, a PEG ratio of 2.80 and a beta of 0.72.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting the consensus estimate of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. During the same period last year, the business posted $0.32 earnings per share. The company’s quarterly revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts predict that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 2nd were issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date was Monday, March 2nd. Corteva’s dividend payout ratio (DPR) is 45.57%.

Analyst Upgrades and Downgrades

CTVA has been the subject of several recent analyst reports. Bank of America raised their target price on Corteva from $80.00 to $82.00 and gave the stock a “buy” rating in a research note on Thursday, January 8th. Argus raised Corteva to a “strong-buy” rating in a research note on Friday, January 16th. Wall Street Zen cut Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Weiss Ratings reissued a “hold (c-)” rating on shares of Corteva in a research report on Monday, December 29th. Finally, JPMorgan Chase & Co. lowered shares of Corteva from an “overweight” rating to a “neutral” rating and boosted their price objective for the company from $75.00 to $77.00 in a report on Thursday, February 5th. One analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $82.90.

Insiders Place Their Bets

In other Corteva news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the sale, the insider directly owned 8,090 shares in the company, valued at $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.14% of the stock is currently owned by corporate insiders.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.